SCHEMBL3288618

SCHEMBL3288618

CC(=CC1(C)CCCCCCCC1)C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.33
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FFAR3 O14843 1/20 0.32
CYP2C19 P33261 1/20 0.30
CD81 P60033 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479260 1.00 PTGS1 (0.33) PTGS1ALDH1A1SMN1; SMN2FFAR3CYP2C19
SCHEMBL3292362 1.00 PTGS1 (0.33) PTGS1ALDH1A1SMN1; SMN2FFAR3CYP2C19
SCHEMBL1334942 1.00 PTGS1 (0.33) PTGS1ALDH1A1SMN1; SMN2FFAR3CYP2C19
SCHEMBL3291244 1.00 PTGS1 (0.33) PTGS1ALDH1A1SMN1; SMN2FFAR3CYP2C19
SCHEMBL5897818 0.98 PTGS1 (0.34) PTGS1FFAR3CD81
SCHEMBL1271391 0.98 PTGS1 (0.34) PTGS1FFAR3CD81
SCHEMBL3287496 0.93 PTGS1 (0.34) PTGS1FFAR3CYP2C19CD81
SCHEMBL3288566 0.89 FFAR3 (0.36) PTGS1FFAR3CD81
SCHEMBL9234899 0.80 CYP2C19 (0.31) PTGS1CYP2C19
SCHEMBL7648537 0.80 CYP2C19 (0.31) PTGS1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186226-B1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2020-06-17 EP disclosed
US-20190171099-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2019-06-06 US disclosed
US-10241399-B2 Polymerizable composition comprising an oxime sulfonate as thermal curing agent BASF SE (DE) 2019-03-26 US disclosed
US-10234761-B2 Oxime ester photoinitiators BASF SE (DE) 2019-03-19 US disclosed
EP-2668156-B1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2018-10-31 EP disclosed
US-20170260132-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2017-09-14 US disclosed
EP-3186226-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2017-07-05 EP disclosed
US-20160377977-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-12-29 US disclosed
EP-3019473-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-05-18 EP disclosed
US-9310677-B2 Polymerizable composition comprising an oxime sulfonate as thermal curing agent BASF (DE) 2016-04-12 US disclosed
US-20160060214-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2016-03-03 US disclosed
WO-2016030790-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2016-03-03 WO disclosed
WO-2015004565-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-01-15 WO disclosed
EP-2668156-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2013-12-04 EP disclosed
US-20130308219-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2013-11-21 US disclosed
WO-2012101245-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT BASF SE (DE) 2012-08-02 WO disclosed
US-7713680-B2 Radiation sensitive resin composition for forming a protective film, method of forming a protective film from the composition, liquid crystal display device and solid-state image sensing device JSR CORPORATION (JP) 2010-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10234761-B2 Oxime ester photoinitiators C9, C5, CBR3 PTGS1 1553/4885ALDH1A1 2225/4885SMN1; SMN2 4340/4885
US-20160377977-A1 OXIME ESTER PHOTOINITIATORS C5, C9, CBR3 PTGS1 1579/4885ALDH1A1 2223/4885SMN1; SMN2 4339/4885
US-10241399-B2 Polymerizable composition comprising an oxime sulfonate as thermal curing agent SULT1E1, COX6B1, SULT1A1 PTGS1 454/4885ALDH1A1 776/4885SMN1; SMN2 2191/4885
US-20170260132-A1 OXIME SULFONATE DERIVATIVES CBR3, CBR1, C1R PTGS1 1872/4885ALDH1A1 1495/4885SMN1; SMN2 3180/4885
US-20190171099-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT SULT1E1, COX6B1, SULT1A1 PTGS1 454/4885ALDH1A1 776/4885SMN1; SMN2 2191/4885
US-20160060214-A1 POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT SULT1E1, COX6B1, SULT1A1 PTGS1 454/4885ALDH1A1 776/4885SMN1; SMN2 2191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.